OPKO Health Files 8-K Report
Ticker: OPK · Form: 8-K · Filed: Jan 15, 2025 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | 8-K |
| Filed Date | Jan 15, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
Related Tickers: OPK
TL;DR
OPKO Health filed an 8-K, likely containing important disclosures. Check for details.
AI Summary
On January 15, 2025, OPKO Health, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates that OPKO Health, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Players & Entities
- OPKO Health, Inc. (company) — Registrant
- January 15, 2025 (date) — Date of earliest event reported
- Miami, Florida (location) — Principal Executive Offices
FAQ
What specific information is being disclosed in this 8-K filing?
The filing indicates it pertains to Regulation FD Disclosure and Financial Statements and Exhibits, but the specific details are not provided in this excerpt.
When was this 8-K report filed?
The report was filed on January 15, 2025.
What is the principal executive office address for OPKO Health, Inc.?
The principal executive offices are located at 4400 Biscayne Blvd., Miami, Florida 33137.
What is OPKO Health, Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number for OPKO Health, Inc. is 75-2402409.
What is the Commission File Number for OPKO Health, Inc.?
The Commission File Number for OPKO Health, Inc. is 001-33528.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-01-15 17:16:06
Key Financial Figures
- $0.01 — ch registered Common Stock , par value $0.01 per share OPK NASDAQ Global Select M
Filing Documents
- opk20250113_8k.htm (8-K) — 28KB
- ex_764946.htm (EX-99.1) — 10KB
- ex99jpm01.jpg (GRAPHIC) — 40KB
- ex99jpm02.jpg (GRAPHIC) — 131KB
- ex99jpm03.jpg (GRAPHIC) — 83KB
- ex99jpm04.jpg (GRAPHIC) — 88KB
- ex99jpm05.jpg (GRAPHIC) — 90KB
- ex99jpm06.jpg (GRAPHIC) — 106KB
- ex99jpm07.jpg (GRAPHIC) — 84KB
- ex99jpm08.jpg (GRAPHIC) — 82KB
- ex99jpm09.jpg (GRAPHIC) — 102KB
- ex99jpm10.jpg (GRAPHIC) — 102KB
- ex99jpm11.jpg (GRAPHIC) — 114KB
- ex99jpm12.jpg (GRAPHIC) — 26KB
- 0001437749-25-001220.txt ( ) — 1611KB
- opk-20250115.xsd (EX-101.SCH) — 3KB
- opk-20250115_def.xml (EX-101.DEF) — 11KB
- opk-20250115_lab.xml (EX-101.LAB) — 15KB
- opk-20250115_pre.xml (EX-101.PRE) — 11KB
- opk20250113_8k_htm.xml (XML) — 3KB
01
ITEM 7.01. Regulation FD Disclosure. On January 15, 2025, members of management for OPKO Health, Inc. (the "Company") attended and will participate in meetings with investors at the 43 rd Annual J.P. Morgan Healthcare Conference. A copy of the Company's presentation materials is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The presentation materials are also available on the Company's website at www.opko.com under Investor Relations. The information contained on the Company's website shall not be deemed part of this report. The information contained in Item 7.01 to this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act of 1933 as amended ("Securities Act") or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 OPKO Health, Inc. Presentation Materials 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPKO Health, Inc. By: /s/ Steven D. Rubin Date: January 15, 2025 Name: Steven D. Rubin Title: Executive Vice President - Administration